Non-linear associations of cardiometabolic index with insulin resistance, impaired fasting glucose, and type 2 diabetes among US adults: a cross-sectional study.
Song J, Li Y, Zhu J, Liang J, Xue S, Zhu Z.
Front Endocrinol (Lausanne). 2024 Feb 12;15:1341828. doi: 10.3389/fendo.2024.1341828. eCollection 2024.
PMID:38410697
Berberine phospholipid exerts a positive effect on the glycemic profile of overweight subjects with impaired fasting blood glucose (IFG): a randomized double-blind placebo-controlled clinical trial.
Rondanelli M, Gasparri C, Petrangolini G, Allegrini P, Avenoso D, Fazia T, Bernardinelli L, Peroni G, Patelli Z, Mansueto F, Tartara A, Cavioni A, Riva A.
Eur Rev Med Pharmacol Sci. 2023 Jul;27(14):6718-6727. doi: 10.26355/eurrev_202307_33142.
PMID:37522683
The Natural Course of Impaired Fasting Glucose.
Święcicka-Klama A, Połtyn-Zaradna K, Szuba A, Zatońska K.
Adv Exp Med Biol. 2021;1324:41-50. doi: 10.1007/5584_2020_571.
PMID:32767267
A Fecal Metabolite Signature of Impaired Fasting Glucose: Results From Two Independent Population-Based Cohorts.
Nogal A, Tettamanzi F, Dong Q, Louca P, Visconti A, Christiansen C, Breuninger T, Linseisen J, Grallert H, Wawro N, Asnicar F, Wong K, Baleanu AF, Michelotti GA, Segata N, Falchi M, Peters A, Franks PW, Bagnardi V, Spector TD, Bell JT, Gieger C, Valdes AM, Menni C.
Diabetes. 2023 Dec 1;72(12):1870-1880. doi: 10.2337/db23-0170.
PMID:37699401
Impaired fasting glucose levels among perinatally HIV-infected adolescents and youths in Dar es Salaam, Tanzania.
Nkinda L, Buberwa E, Memiah P, Ntagalinda A, George M, Msafiri F, Joachim A, Majigo M, Ramaiya K, Sunguya B.
Front Endocrinol (Lausanne). 2022 Dec 6;13:1045628. doi: 10.3389/fendo.2022.1045628. eCollection 2022.
PMID:36561566
Cumulative exposure to impaired fasting glucose and future risk of type 2 diabetes mellitus.
Kim MK, Han K, Koh ES, Hong OK, Baek KH, Song KH, Kwon HS.
Metformin for the prevention of diabetes among people with HIV and either impaired fasting glucose or impaired glucose tolerance (prediabetes) in Tanzania: a Phase II randomised placebo-controlled trial.
Garrib A, Kivuyo S, Bates K, Ramaiya K, Wang D, Majaliwa E, Simbauranga R, Charles G, van Widenfelt E, Luo H, Alam U, Nyirenda MJ, Jaffar S, Mfinanga S; META trial team.